SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-124363
Filing Date
2020-04-29
Accepted
2020-04-29 07:00:34
Documents
5
Period of Report
2020-06-19
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d838855ddef14a.htm DEF 14A 367529
2 GRAPHIC g838855g11t26.jpg GRAPHIC 381975
3 GRAPHIC g838855g29h45.jpg GRAPHIC 27653
4 GRAPHIC g838855g34t00.jpg GRAPHIC 46461
5 GRAPHIC g838855g86q38.jpg GRAPHIC 301178
  Complete submission text file 0001193125-20-124363.txt   1411753
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38707 | Film No.: 20827304
SIC: 2836 Biological Products, (No Diagnostic Substances)